Skip to main content area

Clenil 100 – Available Alternatives

The pharmaceutical company Chiesi have appealed to all Health Care Professionals to help maintain supply by desisting from writing multiple prescriptions for the same products until acute pressures begin to ease.

At the same time, the company issued a statement confirming that their operations are NOT affected by containment measures in place in Italy and that production and distribution of their products continues without limitation or restriction.

Chiesi have also acknowledged issues with supply of Clenil 100 metered dose inhalers – linked to unprecedented demand. The company anticipates being unable to meet the current increase in demand – and cannot guarantee uninterrupted supply over the next month. NO other Chiesi products are affected.